Echocardiographic diagnosis of carcinoid tumours;Apport de l'echocardiographie dans le diagnostic des tumeurs carcinoides. A propos de 4 observations

Archives des Maladies du Coeur et des Vaisseaux

Volumn 93, Issue 3, 2000, Pages 277-283

  Avierinos J F ^b   Habib, G ^b   Garcia, M ^b   Lefevre J ^b   Medail C ^b   Dufaut, F ^b   Philip, E ^b   Ambrosi, P ^b   Perrier, H ^b   Luccioni, R ^a  

^a TIMONE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; OCTREOTIDE; STREPTOZOCIN;

AGED; ARTICLE; CARCINOID; CASE REPORT; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; HEART RIGHT VENTRICLE; HEART TUMOR; HUMAN; MALE; PROGNOSIS; TUMOR DIAGNOSIS; CARCINOID SYNDROME; ECHOCARDIOGRAPHY; ECHOGRAPHY; PATHOLOGY;

AGED; CARCINOID HEART DISEASE; CARCINOID TUMOR; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE;

EID: 0034154893     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Monsegu J, Algayres JP, Ciribilli JM et al. Une insuffisance tricuspidienne révélatrice d'un syndrome carcinoide. Rev Med Interne 1994 ; 15 (9) : 593-6.
2. Lachter JH, Lavy A, Eidelman S. Right heart failure as the sole presentation or carcinoid syndrome. Int J Cardiol 1989 ; 25 (1) : 129-30.
3. Robiolio PA, Rigolin VH, Harrison JK et al. Carcinoid heart disease: correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation 1995 ; 92 (4) : 790-5.
4. Lundin L, Norheim I, Landelius J, Oberg K, Thedorsson-Norheim E. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound detectable cardiac abnormalities. Circulation 1988 ; 77 (2) : 264-9.
5. Pellikka PA, Tajik AJ, Khanderia BK et al. Carcinoid heart disease: clinical and echocardiogrophic spectrum in 74 patients. Circulation 1993 ; 87 : 1188-96.
6. Bianchine JR, Macaraeg PV, Brandes D et al. Serotonin and fibrosis. Arch Intern Med 1968 ; 122 ; 167-70.
7. Tribouilloy C, Slama MA, Rey JL et al. Démonstration par échodoppler d'une atteinte polyvalvulaire au cours d'une cardiopathie carcinoide. Arch Mal Cœur 1989 ; 82 (1): 109-14
8. Moyssakis IE, Rallidis LS, Guida GF, Nihoyannopoulos PI. Incidence and evolution of carcinoid syndrome in the heart. J Heart Valve Dis 1997 ; 6 : 625-30.
9. Lundin L, Landelius J, Andren B Oberg K. Transoesophageal echocardiography improves the diagnostic value of cardiac ultrasound in patients with carcinoid heart disease. Br Heart J 1990 ; 64 (3): 190-4.
10. Weissman NJ, Tighe JF Jr, Gottdiener JS, Gwynne JT. An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group. N Engl J Med 1998 ; 339 (11): 725-32.
11. Redfield M, Nicholson W, Edwards W, Tajik A. Valve desease associated with ergot alcaloid use. Ann Intern Med 1992 ; 117 : 50-2.
12. Kvols LK, Moertel CG, Oconnel MJ, Schutt AJ, Rubin J, Hahn RG. Treatment of the malignant carcinoid syndrome: evaluation of a long-acting somatostatin analogue. N Engl J Med 1986 ; 315 : 663-6.
13. Connolly HM, Nishimura RA, Smith HC et al. Outcome of cardiac surgery for carcinoid heart disease. J Am Coll Cardiol 1995 ; 25 : 410-6.
14. Knott-Craig CJ, Schaff HV, Mullany CJ et al. Carcinoid disease of the heart. Surgical management of ten patients. J Thorac Cardiovasc Surg 1992 ; 104 (2): 475-81
15. Rayson D, Pitot H, Kvols L. Regression of metastatic carcinoid tumour after valvular surgery for carcinoid heart disease. Cancer 1997 ; 79 : 605-11.